Pionyr

Biopharma takeovers show quantity, if not quality
EP Vantage
Mon, 07/13/20 - 11:13 am
COVID-19
pandemic
M&A
Novo Nordisk
Corvidia
Gilead Sciences
Pionyr
Alexion
Portola Pharmaceuticals
Menarini
Stemline Therapeutics
Shionogi
Tetra Therapeutics
Gilead pens $1.5B buyout option deal for Pionyr
Fierce Biotech
Tue, 06/23/20 - 10:50 am
Gilead Sciences
Pionyr
M&A
immuno-oncology
Yervoy inventor’s oncology startup Pionyr gets $62M for tumor-fighting tech
Endpoints
Wed, 12/13/17 - 11:11 am
Yervoy
oncology
Pionyr